Edition:
United States

Cassiopea SpA (SKIN.S)

SKIN.S on Swiss Exchange

40.60CHF
14 Dec 2018
Change (% chg)

CHF-1.60 (-3.79%)
Prev Close
CHF42.20
Open
CHF42.70
Day's High
CHF43.50
Day's Low
CHF40.10
Volume
3,120
Avg. Vol
8,047
52-wk High
CHF61.40
52-wk Low
CHF30.00

Chart for

About

Cassiopea SpA is an Italy-based company engaged in the biotechnology and medical research industry. The Company is a clinical stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products. The Company's current focus is on the topical treatment of... (more)

Overall

Beta: --
Market Cap(Mil.): CHF330.00
Shares Outstanding(Mil.): 10.00
Dividend: --
Yield (%): --

Financials

  SKIN.S Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -2.07 -- --
ROI: -22.00 15.55 14.96
ROE: -22.00 16.92 16.52

BRIEF-Cassiopea: Attainment Of All Primary And Secondary Endpoints In Phase 3 For Winlevi Cream

* ATTAINMENT OF ALL PRIMARY AND SECONDARY ENDPOINTS AND HIGHLY SATISFACTORY SAFETY DATA IN ITS PHASE 3 FOR WINLEVI (CLASCOTERONE) CREAM IN TREATING ACNE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 18 2018

BRIEF-Cassiopea Enters Into Loan Agreement With Cosmo Pharmaceuticals

* COSMO PHARMACEUTICALS HAS OFFERED AN UNSECURED CREDIT LINE OF EUR 10 MILLION THAT CAN BE INCREASED TO EUR 20 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 11 2018

BRIEF-Cassiopea: Top Line Positive Proof Of Concept Phase II Results For Cb-06-02 Immune Modulator In Treating Genital Warts

* CASSIOPEA ANNOUNCES TOP LINE POSITIVE PROOF OF CONCEPT PHASE II RESULTS FOR CB-06-02 IMMUNE MODULATOR IN TREATING GENITAL WARTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 19 2018

BRIEF-Cassiopea H1 Loss After Taxes At EUR 6.7 Mln

* VERY POSITIVE TOP LINE PHASE III RESULTS FOR WINLEVI(R) (CLASCOTERONE) IN TREATING ACNE

Jul 18 2018

BRIEF-Cassiopea Announces Positive Interim Analysis Phase 2 Results For Breezula

* ANNOUNCES VERY POSITIVE INTERIM ANALYSIS PHASE 2 RESULTS FOR BREEZULA IN TREATING ANDROGENETIC ALOPECIA

Jul 16 2018

BRIEF-Cassiopea: Very Positive Top-Line Phase 3 Results For Winlevi Cream

* VERY POSITIVE TOP-LINE PHASE 3 RESULTS FOR WINLEVI® (CLASCOTERONE) CREAM IN TREATING ACNE

Jul 10 2018

Earnings vs. Estimates